Research Press Releases
Real results start with real research. Explore the scientific studies behind Symprove - rigorously tested, transparently shared.
New study explores potential role of gut health in multiple sclerosis
New research presented at the Multiple Sclerosis Trust Annual Conference 2025 is adding to growing scientific interest in the relationship between the gut microbiome and neurological conditions suc...
Symprove case series in rare skin condition at Great Ormond Street Hospital
Researchers have explored whether the multi-strain liquid probiotic Symprove could help improve gastrointestinal symptoms in children with severe recessive dystrophic epidermolysis bullosa (RDEB-S)...
New study explores the link between the gut microbiome and Parkinson's disease
A laboratory study has investigated whether the multi-strain liquid probiotic Symprove could influence changes to the gut microbiome associated with Parkinson’s disease.
Published in International ...
Real-world study reports improvements in IBS with a liquid probiotic
A real-world study involving more than 1,200 people with irritable bowel syndrome (IBS) or IBS-like symptoms has reported improvements in digestive symptoms and quality of life following four or m...
Study explores Symprove effects on the gut microbiome in ulcerative colitis
Researchers have published a laboratory study investigating the effects of the multi-strain liquid probiotic Symprove on the gut microbiome for people with ulcerative colitis.
Published in the Inte...
Clinical trial explores potential role of probiotics in inflammatory bowel disease
A clinical trial has investigated the effects of the multi-strain liquid probiotic Symprove in people with inflammatory bowel disease (IBD), assessing its effects on quality of life, disease activi...
Symprove modulates the immune system through beneficial gut compounds
A new in vitro study has demonstrated Symprove’s ability to bacteria thrive within the gut and modulate the immune system through production of short-chain fatty acids, particularly butyrate, and i...
Laboratory study shows Symprove inhibits common gut pathogens
A laboratory study has shown that the multi-strain liquid probiotic Symprove can inhibit several harmful bacteria commonly associated with gastrointestinal infections.
Infectious diarrhoea remains ...
Clinical trial finds Symprove may support patients with diverticular disease
A randomised, double-blind, placebo-controlled clinical trial has found that the multi-strain liquid probiotic Symprove significantly reduced the frequency of constipation, diarrhoea, mucorrhoea an...
